FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048286308> ?p ?o ?g. }

• W3048286308 endingPage "406" @default.
• W3048286308 startingPage "397" @default.
• W3048286308 abstract "Abstract: The ongoing COVID-19 pandemic has produced serious turmoil world-wide. Lung injury causing acute respiratory distress syndrome seems to be a most dreaded complication occurring in ∼30%. Older patients with cardiovascular comorbidities and acute respiratory distress syndrome have an increased mortality. Although the precise mechanisms involved in the development of lung injury have not been fully elucidated, the role of the extended renin–angiotensin system seems to be pivotal. In this context, angiotensin-converting enzyme 2 (ACE2), an angiotensin-converting enzyme homologue, has been recognized as a facilitator of viral entry into the host, albeit its involvement in other counter-regulatory effects, such as converting angiotensin (Ang) II into Ang 1–7 with its known protective actions. Thus, concern was raised that the use of renin–angiotensin system inhibitors by increasing ACE2 expression may enhance patient susceptibility to the COVID-19 virus. However, current data have appeased such concerns because there has been no clinical evidence of a harmful effect of these agents as based on observational studies. However, properly designed future studies will be needed to further confirm or refute current evidence. Furthermore, other pathways may also play important roles in COVID-19 transmission and pathogenesis; spike (S) protein proteases facilitate viral transmission by cleaving S protein that promotes viral entry into the host; neprilysin (NEP), a neutral endopeptidase known to cleave natriuretic peptides, degrades Ang I into Ang 1–7; NEP can also catabolize bradykinin and thus mitigate bradykinin's role in inflammation, whereas, in the same context, specific bradykinin inhibitors may also negate bradykinin's harmful effects. Based on these intricate mechanisms, various preventive and therapeutic strategies may be devised, such as upregulating ACE2 and/or using recombinant ACE2, and exploiting the NEP, bradykinin and serine protease pathways, in addition to anti-inflammatory and antiviral therapies. These issues are herein reviewed, available studies are tabulated and pathogenetic mechanisms are pictorially illustrated." @default.
• W3048286308 created "2020-08-13" @default.
• W3048286308 creator A5010387621 @default.
• W3048286308 creator A5032949159 @default.
• W3048286308 creator A5055500199 @default.
• W3048286308 creator A5077184276 @default.
• W3048286308 date "2020-10-01" @default.
• W3048286308 modified "2023-10-01" @default.
• W3048286308 title "The Controversy of Renin–Angiotensin-System Blocker Facilitation Versus Countering COVID-19 Infection" @default.
• W3048286308 cites W1572914688 @default.
• W3048286308 cites W1782255168 @default.
• W3048286308 cites W1915110884 @default.
• W3048286308 cites W1964982019 @default.
• W3048286308 cites W1996544592 @default.
• W3048286308 cites W2000040025 @default.
• W3048286308 cites W2001411396 @default.
• W3048286308 cites W2005266131 @default.
• W3048286308 cites W2015945747 @default.
• W3048286308 cites W2029269323 @default.
• W3048286308 cites W2030499792 @default.
• W3048286308 cites W203335766 @default.
• W3048286308 cites W2038602036 @default.
• W3048286308 cites W2038966354 @default.
• W3048286308 cites W2070459088 @default.
• W3048286308 cites W2072628367 @default.
• W3048286308 cites W2079891381 @default.
• W3048286308 cites W2081719521 @default.
• W3048286308 cites W2091671824 @default.
• W3048286308 cites W2101610495 @default.
• W3048286308 cites W2110202498 @default.
• W3048286308 cites W2126091764 @default.
• W3048286308 cites W2167628326 @default.
• W3048286308 cites W2206559282 @default.
• W3048286308 cites W2337855427 @default.
• W3048286308 cites W2562411701 @default.
• W3048286308 cites W2756541052 @default.
• W3048286308 cites W2769538603 @default.
• W3048286308 cites W2809452578 @default.
• W3048286308 cites W2890618895 @default.
• W3048286308 cites W2912196127 @default.
• W3048286308 cites W2940478411 @default.
• W3048286308 cites W2954603315 @default.
• W3048286308 cites W3001118548 @default.
• W3048286308 cites W3007859670 @default.
• W3048286308 cites W3008090866 @default.
• W3048286308 cites W3008295344 @default.
• W3048286308 cites W3009912996 @default.
• W3048286308 cites W3010819577 @default.
• W3048286308 cites W3011755245 @default.
• W3048286308 cites W3011995143 @default.
• W3048286308 cites W3013155528 @default.
• W3048286308 cites W3013442544 @default.
• W3048286308 cites W3013800395 @default.
• W3048286308 cites W3014027512 @default.
• W3048286308 cites W3015660580 @default.
• W3048286308 cites W3016176352 @default.
• W3048286308 cites W3016259848 @default.
• W3048286308 cites W3016726004 @default.
• W3048286308 cites W3017125154 @default.
• W3048286308 cites W3017176386 @default.
• W3048286308 cites W3017200596 @default.
• W3048286308 cites W3017304234 @default.
• W3048286308 cites W3017331996 @default.
• W3048286308 cites W3017545174 @default.
• W3048286308 cites W3018529391 @default.
• W3048286308 cites W3019130299 @default.
• W3048286308 cites W3019849260 @default.
• W3048286308 cites W3020423761 @default.
• W3048286308 cites W3020512604 @default.
• W3048286308 cites W3020695284 @default.
• W3048286308 cites W3021640348 @default.
• W3048286308 cites W3022120179 @default.
• W3048286308 cites W3022149127 @default.
• W3048286308 cites W3022435472 @default.
• W3048286308 cites W3022757001 @default.
• W3048286308 cites W3022894063 @default.
• W3048286308 cites W3023149274 @default.
• W3048286308 cites W3023640683 @default.
• W3048286308 cites W3023751598 @default.
• W3048286308 cites W3024068183 @default.
• W3048286308 cites W3024420022 @default.
• W3048286308 cites W3025099648 @default.
• W3048286308 cites W3025862068 @default.
• W3048286308 cites W3026328714 @default.
• W3048286308 cites W3027038018 @default.
• W3048286308 cites W3027255028 @default.
• W3048286308 cites W3027880418 @default.
• W3048286308 cites W3028729845 @default.
• W3048286308 cites W3029048120 @default.
• W3048286308 cites W3029479164 @default.
• W3048286308 cites W3030682068 @default.
• W3048286308 cites W3030868216 @default.
• W3048286308 cites W3031140136 @default.
• W3048286308 cites W3033090821 @default.
• W3048286308 cites W3034304416 @default.
• W3048286308 cites W3035991188 @default.
• W3048286308 cites W3036500066 @default.
• W3048286308 cites W3037521489 @default.

• next